Safety, Tolerability, and Clinical Pharmacology of ANX009, an Inhibitory Antibody Fab Fragment Against C1q, Administered Subcutaneously to Healthy Volunteers
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Anita Grover, Jeffrey Teigler, Emily Radomile, Shawn Rose, Ted Yednock, Sanjay Keswani, Henk-Andre Kroon
Institution: Annexon Biosciences (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3213745057